Advancing Schizophrenia Care: Challenges and Promising New Therapies
Advancing Schizophrenia Care: Challenges and Promising New Therapies
DOAC does not prevent cognitive decline in adults with AF and a low risk of stroke
DOAC does not prevent cognitive decline in adults with AF and a low risk of stroke
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Recognizing Agitation in Alzheimer’s Dementia: A Screening Tool for Caregivers
Recognizing Agitation in Alzheimer’s Dementia: A Screening Tool for Caregivers
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
Hand-in-Hand: Walking Patients Through Their Journey with a Therapy for Early Alzheimer’s Disease (AD)
Hand-in-Hand: Walking Patients Through Their Journey with a Therapy for Early Alzheimer’s Disease (AD)
Patient-Centric Care for Managing Certain Manifestations of VHL Disease
Patient-Centric Care for Managing Certain Manifestations of VHL Disease
Long-Term Subcutaneous Immunoglobulin (SCIg) in CIDP: The Maintenance Phase
Long-Term Subcutaneous Immunoglobulin (SCIg) in CIDP: The Maintenance Phase
Managing MS: The Role of Immunoglobulins in the Immune System and Long-Term Safety Data for a B-Cell RMS Therapy
Managing MS: The Role of Immunoglobulins in the Immune System and Long-Term Safety Data for a B-Cell RMS Therapy
medicalxpress.com
drexel.edu
prnewswire.com
medicalxpress.com
cleveland.com
michiganmedicine.org
